The phrase "as a psa" is not correct in standard written English.
It appears to be an abbreviation or shorthand that may not be widely recognized without context.
Example: "As a psa, please remember to submit your reports by Friday."
Alternatives: "as a public service announcement" or "as a reminder".
After prostatectomy, BCR is defined by the American Urological Association as a PSA value of 0.2 ng/mL or higher on two separate tests [1].
The NHS believes the current test for prostate cancer - a blood test known as a PSA - is not reliable enough for a national screening programme.
If this doesn't serve as a PSA for not sending photos of your private parts, we're not sure what will.
Yet, as a PSA, let me remind you of the ongoing Saul Alinsky style psyop in play to suppress #FreeSpeech.
Partnering with actress Shoshana B. Roberts and Hollaback, a nonprofit movement launched by activists to end street harassment, Bliss packaged his production as a PSA and offers viewers a different perspective on the problem.
This is full-on hilarious, and so much nachas, too: Sarah Silverman has launched what definitely qualifies as a PSA in her latest video imploring young Jews to head down to Florida to convince their grandparents to vote for Barack Obama.
Biochemical recurrence was defined as a PSA-level of at least 0.2 ng ml−1 after prostatectomy, confirmed at least once, or as a rise in PSA-level of at least 0.5 ng ml−1 after radiotherapy, confirmed at least once.
Our estimates of the impact of a range of PSA contamination rates (defined as ever having a PSA test during follow-up, as in ERSPC (de Koning et al, 2002)), suggest that the effect of contamination is minimal unless it reaches 20%, a level unlikely in this trial (Williams et al, 2011).
The main objective of this study was to examine the self-reported health status in patients with RA, AS and PsA, compared with a selected sample of health people.
GLM has been confirmed to be an effective treatment for patients with RA (including those naïve to MTX, those inadequately responsive to MTX, and those previously treated with a TNF inhibitor), AS, and PsA in phase III clinical trials that have included traditional measures of disease activity and functional decline.
Included patients with a diagnosis of RA, AS or PsA, IBD, or PS.
